03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Meropenem Labatec 1g : | |
Type | Medicine Authorised |
Originator | Meronem 1g |
Agent | Levant Alie Houses |
Distributor | Levant Alie Houses |
Laboratory | Labatec Pharma |
Responsible Party | Labatec Pharma SA |
Origin | Switzerland |
Manufacturer | ACS Dobfar SPA |
Manufacturing Type | G |
Origin | Italy |
ATC | J01DH02 |
Meropenem Labatec 1g :
Meropenem Labatec 1g :
Meropenem Labatec 1g :
Meropenem Labatec 1g :
Meropenem Labatec 1g :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Agranulocytosis | Uncommon |
Anaphylaxis | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Uncommon |
Antibiotic associated colitis | Uncommon |
Blood bilirubin increased | Uncommon |
Blood lactate dehydrogenase increased | Common |
Blood urea increased | Uncommon |
Cephalea | Common |
Convulsion | Rare |
Creatinine increased | Uncommon |
Diarrhoea (Diarrhea) | Common |
Eosinophilia | Uncommon |
Erythema multiforme | Uncommon |
Haemolytic anemia | Uncommon |
Inflammation (Inflammatory reaction) | Common |
Injection site pain | Uncommon |
Leucopenia (Leukopenia) | Uncommon |
Lyell Syndrome (Toxic epidermal necrolysis) | Uncommon |
Nausea | Common |
Neutropenia | Uncommon |
Oral candidiasis | Uncommon |
Pain | Common |
Phosphatase alkaline increased | Common |
Pruritus | Common |
Skin Eruption | Common |
Stevens-Johnson syndrome | Uncommon |
Thrombocythaemia | Common |
Thrombocytopenia (Thrombopenia) | Uncommon |
Thrombophlebitis | Uncommon |
Transaminases increased | Common |
Urticaria | Uncommon |
Vaginal candidiasis | Uncommon |
Vomiting | Common |
Meropenem Labatec 1g :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Meropenem Labatec 1g MoH 6542 :
Form | Powder for solution for infusion |
Packaging | Bottle |
Package Size | Box of 10 |
Strength | 1g |
Storage Condition | <30°C Do not freeze |
Public Price | 12764390.82 L.L. |
Stratum | C |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 166843/11 |
Submission date | 01/01/2011 |
Registration Year | 2012 |
Archived Date | 02/03/2023 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 10 | |
● Public Price: | 293.65 CHF | ( 30,369,283.00 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 29,365 CHF | ( 2,999,180.00 LBP ) |
● Exfactory Price: | 241.5 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 10 Glass Vials (Powder) | |
● Public Price: | 791 AED | ( 19,111,351.00 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 79,1 AED | ( 1,908,719.00 LBP ) |
● Pharmacy Price: | 673.89 AED | ( 16281856.29 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 10 | |
● Public Price: | 89.14 OMR | ( 20,567,628.76 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 8,914 OMR | ( 1,845,872.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 10 | |
● Public Price: | 75.15 BHD | ( 17,865,710.10 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 7,515 BHD | ( 1,664,138.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Powder for solution for infusion | |
● Package Size: | Box of 10 | |
● Public Price: | 12764390.82 LBP | ( 12,764,390.82 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 1276439,08 LBP | ( 1,276,439.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Abu Dhabi | |
● Package Size: | 10 | |
● Public Price: | 500.5 AED | ( 12,092,580.50 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 50,05 AED | ( 1,208,050.00 LBP ) |
● Pharmacy Price: | 414.12 AED | ( 10005553.32 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy |
● Package Size: | 10 |
● Medica Comments: | Not available in the country of origin |
● Pricing Date: | 14/10/2019 |
● Type: | Medicine not available |
You have to register to view this info
Drop File